Life ScienceCompany
La Jolla Pharmaceutical M&A Summary
La Jolla Pharmaceutical has acquired 2 companies of its own, including 1 in the last 5 years.
La Jolla Pharmaceutical’s largest acquisition to date was in 2020, when it acquired Tetraphase Pharmaceuticals for $43M. La Jolla Pharmaceutical has acquired in 2 different US states. The Company’s most targeted sectors include life science (50%) and medical products (50%).
La Jolla Pharmaceutical Ownership
Who owns La Jolla Pharmaceutical?
La Jolla Pharmaceutical is owned by Innoviva. It was acquired on July 11, 2022.
La Jolla Pharmaceutical Business Overview
Where is La Jolla Pharmaceutical headquartered?
La Jolla Pharmaceutical is headquartered in Waltham, Massachusetts.
What is La Jolla Pharmaceutical’s revenue?
La Jolla Pharmaceutical disclosed revenue of 76M USD for 2021 and 33M USD for 2020.
What sector is La Jolla Pharmaceutical in?
La Jolla Pharmaceutical is a life science company.
When was La Jolla Pharmaceutical founded?
La Jolla Pharmaceutical was founded in 1989.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity2
- Total Sectors Invested 2
- Total Countries Invested 1
Unlimited Searches
